Laharie D. Drug monitoring: Pro. UEG Week 2018, IP003.,D’Haens G. Drug monitoring: Con. UEG Week 2018, IP004.
Zolbetuximab plus mFOLFOX6 verbetert overleving bij adenocarcinoom van de maag of gastro-oesofageale overgang
sep 2023 | Maag-darm-leveroncologie